SuperTails/D2C / PET CARE / E-COMMERCEUpdated: 04 May 2026

SuperTails Has ₹23 Lakh Cash. Revenue Is ₹120 Cr.

SuperTails revenue, PAT, debt and cash flow — from the AOC-4 XBRL Standalone Financial Statements FY2025, Pets Centric Private Limited.

₹120 Cr
FY2025 Revenue
-₹30 Cr
FY2025 Net Loss
14.7x
Advertising Growth
₹23 Lakh
Cash on Hand
UnpopularVoice Editorial7 min read  ·  Financial deep dive
What the numbers actually say12 metrics
MetricReported(Narrative)Economic Reality
FY2025 Revenue₹120.43 Crup from ₹69.69 Cr (+72.8%)
FY2025 Net Loss-₹29.97 Crloss tripled from -₹9.11 Cr in FY2024 (+229%)
Loss as % of Revenue25%worsened from 13% in FY2024
Cost of Stock-in-Trade₹94.52 Cr78.5% of revenue; gross margin 21.5%
Advertising & Promotion₹12.27 Crup 14.7x from ₹0.83 Cr
Other Expenses₹47.22 Crup 136% from ₹20.02 Cr
Employee Benefits₹11.02 Crup from ₹0.99 Cr; large jump suggests classification or hiring shift
Operating Cash Flow-₹15.65 Crburn worsened from -₹0.47 Cr
Financing Cash Flow+₹17.60 Crfresh equity raised during the year
Total BorrowingsZerono debt, current or non-current
Cash and Bank Balances₹0.23 Crdown from ₹0.66 Cr; ~22 days of operating burn
Current InvestmentsZerono treasury cushion

The 30-Second Summary

SuperTails has ₹23 lakh in cash.

It does ₹120 Cr in revenue.

The company spent ₹95 Cr buying inventory, ₹47 Cr on operations, and ₹12 Cr on marketing. Revenue was ₹120 Cr. Loss was ₹30 Cr. The arithmetic doesn't close, and the cash balance is what's left after the year.

SuperTails is not scaling a business. It is financing a category bet.

Growth is visible. Unit economics are not.

What changed in FY2025?

  • Revenue grew 73%: ₹70 Cr to ₹120 Cr.
  • Loss tripled: ₹9 Cr to ₹30 Cr.
  • Advertising scaled 14.7x: ₹0.83 Cr to ₹12.27 Cr; the largest percentage jump in the P&L.
  • Other expenses grew 136%: ₹20 Cr to ₹47 Cr; logistics and operating costs scaled faster than revenue.
  • Operating cash burn worsened: from -₹0.47 Cr to -₹15.65 Cr.
  • Cash on hand fell: ₹66 lakh to ₹23 lakh.
  • Fresh equity raised: approximately ₹17.6 Cr in FY2025, roughly matching the operating burn.

The 21.5% Gross Margin Problem

For every ₹100 of revenue SuperTails generated in FY2025, it spent ₹78.50 buying the inventory. Gross profit was ₹21.50 per ₹100 of sales.

Pet food, the dominant category in pet care, is thin-margin and brand-dominated. Pedigree, Royal Canin, Drools, and Whiskas set the wholesale prices the platform pays. Margin expansion comes from own-label scale or a mix shift to accessories and wellness. The audit doesn't break revenue by category, so the higher-margin share isn't visible.

What the math constrains: ₹26 Cr of gross profit has to absorb a ₹74 Cr operating cost stack (employees + advertising + other expenses + finance + depreciation). The ₹48 Cr gap is the operating loss before any working capital effect.

The core insight

SuperTails earned ₹26 Cr in gross profit. It spent ₹74 Cr running the business. The ₹48 Cr difference is what the next funding round has to cover.

The Marketing That Grew 14.7x

The single most striking line in the FY2025 P&L is advertising and promotion: ₹12.27 Cr, up from ₹0.83 Cr in FY2024.

A 14.7x increase in absolute spend on a 73% increase in revenue is not a marketing optimisation; it is a marketing acceleration. The company chose to deploy a multi-fold larger budget to acquire customers, betting that the lifetime value of those customers will eventually justify the cost.

For a category like pet care, this can work. Pet owners typically buy from the same platform repeatedly (food is a recurring purchase), and switching costs increase with subscription plans, vet records, and saved preferences. A customer acquired in FY2025 may generate revenue across the next several years.

For the FY2025 P&L, however, all the cost is recognised in the year of acquisition, while only a fraction of the lifetime revenue is. The audit will look worst at the moment of fastest acquisition. SuperTails is at that moment now.

The other operating-cost line growing 136% (₹20 Cr to ₹47 Cr) is the second mover. Logistics costs (cold-chain for prescription medications, last-mile delivery), platform commissions on marketplaces, and operational overhead all scale with order volume. These costs typically dilute as average order value grows; SuperTails has not yet shown that effect in FY2025.

The Cash Balance That Is Not a Cushion

Cash and bank balances at year-end: ₹23 lakh.

A revenue business doing ₹10 Cr per month is operating with three weeks of cash on hand. There is no current investments cushion (₹0 in this category at year-end). There is no working-capital line of credit (₹0 in borrowings). The capital structure is entirely equity, and the equity is fully deployed.

The financing cash flow of +₹17.60 Cr during FY2025 indicates a fresh equity tranche was drawn in the year. That tranche funded approximately the operating burn (₹15.65 Cr OCF + ₹2.38 Cr investing = ₹18.03 Cr total cash demand). The company is operating in tight synchronisation with its funding pipeline: each new tranche covers approximately the next year's burn.

This works as long as the next tranche keeps arriving. SuperTails has institutional backing (Saama, RPSG, DSG, others) and operates in a category that continues to attract investment. A Series B or another Series A1 tranche in the next 12 months is a reasonable expectation. The audit shows the runway is ~8-12 months from the next milestone, not from an absolute end-point.

The Question for FY2026

The FY2025 audit defines the next year's questions sharply.

Will the gross margin improve? The 21.5% gross margin is the binding constraint. If the product mix shifts toward higher-margin categories (own-label food, accessories, wellness services), each new ₹100 of revenue generates more absorbable gross profit. If it doesn't, the business needs revenue at much larger scale to break even.

Will the marketing efficiency mature? A 14.7x advertising increase is one-time in nature. It cannot continue at this rate. The question is what fraction of the FY2025 customers convert to repeat-purchase cohorts, and at what cost-per-cohort the FY2026 spend can be calibrated. If the customer base from FY2025 is genuinely repeat-buying and product-loyal, FY2026 advertising can grow more modestly while revenue continues to compound.

Will the next funding round arrive on time? The audit shows the company is operating with thin cash and no debt. The funding pipeline is the operating runway. Pet-care has been a growing investment category in India, with multiple players (Heads Up For Tails, Wiggles, Drools' direct channel). Continued investor appetite is the precondition for SuperTails's plan to play out.

This is a high-cost growth phase that depends on the next round. The institutional backing and the funding cadence are real, but the model works only if the next tranche keeps arriving while the unit economics catch up. Whether they catch up is the question that the FY2026 audit will answer.

Employer Health Signal

SuperTails (Pets Centric Private Limited)

Filing: FY2025 standaloneMCA audited data
Worth watching

Growth Momentum

YoY revenue growth rate, whether growth is from continuing operations, cost trajectory

Growing

Stability

Cash + liquid assets vs burn, debt structure, operating cash flow

Watch

Profitability

PAT direction, cost-to-income ratio trend, operating leverage signals

Loss-Deepening

Funding Dependence

How much of operations is funded by equity raises vs revenue

High

Career Upside

Revenue growth + payroll signals + ESOP structure + company stage

Moderate

Notes

SuperTails is buying the pet-care category. Revenue grew 73% in FY2025; the loss tripled. Gross margin was 21.5% (cost of stock-in-trade was 78.5% of revenue), which is thin for a D2C business and constrains the absorption capacity for marketing and operating costs. The advertising line grew 14.7x. Cash on hand at year-end was ₹23 lakh, with a fresh ₹17.6 Cr equity raise during the year roughly matching the operating burn. Zero debt; continued institutional backing.

What the filing confirms

  • Revenue grew 73% to ₹120 Cr; pet-care category is scaling.
  • Zero debt: capital structure is entirely equity, no fixed obligations.
  • Fresh equity raised in FY2025 (~₹17.6 Cr) consistent with active investor support.
  • Repeat-purchase economics in pet food can compound; FY2025 customer cohorts will determine FY2026 efficiency.

Risk flags from filing

  • Loss tripled in twelve months while revenue grew 73%; trajectory is going the wrong way.
  • Cost of stock-in-trade is 78.5% of revenue; gross margin of 21.5% leaves thin absorption room.
  • Advertising spend grew 14.7x: cost-per-acquisition is high and must mature.
  • Cash on hand was ₹23 lakh at year-end: less than a month's burn with no debt or treasury cushion.
  • Other operating expenses (logistics, platform, operations) grew 136%, faster than revenue.

Disclaimer: This signal is derived from audited financial filings only. It does not assess culture, management quality, career growth environment, team dynamics, or working conditions. A strong signal means the financial floor is solid. A weak signal means financial risk is present. Neither replaces your own due diligence. Scoring methodology →

Key Takeaways5 points
1Pets Centric Private Limited (SuperTails, CIN U52609KA2021PTC146482) reported FY2025 standalone revenue of ₹120.43 Cr (+72.8%) and net loss of ₹29.97 Cr (loss tripled from ₹9.11 Cr in FY2024).
2Cost of stock-in-trade was ₹94.52 Cr, or 78.5% of revenue. Gross margin was approximately 21.5%, thin for a D2C business.
3Advertising and promotion expense grew from ₹0.83 Cr to ₹12.27 Cr (14.7x increase). Other expenses (logistics, platform fees, operations) grew 136% to ₹47.22 Cr. Employee benefits expense grew from ₹0.99 Cr to ₹11.02 Cr.
4Operating cash flow worsened from -₹0.47 Cr to -₹15.65 Cr. Cash and bank balances at year-end were ₹23 lakh, down from ₹66 lakh.
5Financing cash flow of +₹17.60 Cr indicates fresh equity raised during FY2025, broadly funding the operating cash burn. Zero borrowings on the balance sheet.